BillionToOne, Inc.
NASDAQ:BLLNMedical - Diagnostics & Research
+$0.84 today
- Market cap
- $4.37B
- Beta
- 0.90
- P/E (TTM)
- 182.6
- EPS (TTM)
- $0.55
Volume 1.44M
Average 0.59M
BLLN Net Income
Bottom-line profit, the starting point for calculating cash from operations.
BillionToOne, Inc.NASDAQ: BLLN
Net Income · Q2 FY2026 · quarter ended Jun 2026
Net income turns positive
Q2 FY2026 net income was $8.05M, compared with -$1.34M a year earlier. Trailing-twelve-month net income was $37.71M.
Context
- Net income amounted to 1.0% of revenue in FY2025, down 26.3 pp from a year earlier.
- Net income increased in 2 of the last 2 fiscal years.
- FY2025 was the highest annual figure in the 3 fiscal years shown.
What to watch
Whether net income reaches the consensus estimate from 5 analysts of $18.97M (+549.9%) for the fiscal year ending Dec 2026, a step up from the +107.0% reported in FY2025.
Sources:Cash Flow Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJun 2026
- $8.05M-55.2% QoQ
- Last fiscal yearDec 2025
- $2.92M+107.0% YoY
- LTMJun 2026
- $37.71M— YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +703.3% | +37.3% | -666.0 pp |
| 1 year | +107.0% | +549.9% | +442.9 pp |
| 3-year CAGR | — | +135.9% | — |
| 5-year CAGR | +83.9% | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Net Income history
USD · from the cash flow
- Latest · FY2025
- 2.92M USD
- Year-over-year change
- +107.0%
| Period | Period end | Net Income | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 2.92M | +107.0% |
| FY2024 | 2024-12-31 | (41.57M) | +49.7% |
| FY2023 | 2023-12-31 | (82.68M) | — |
Net Income vs competitors
How BLLN compares with its peers on the latest reported figures
- BLLN's LTM Jun 2026 net income of $37.71M is the smallest of the 9 companies compared; the peer median is $149.35M.
- Net income amounts to 9.5% of revenue for BLLN, versus a peer median of 23.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $485.07M | +21.6% | -14.0% | 37.9% | |
| LTM Mar 2026 | $399.9M | +294.4% | +48.4% | 48.2% | |
| LTM Jun 2026 | $391.59M | -11.6% | -57.7% | 236.9% | |
| LTM Jun 2026 | $192.35M | -24.0% | -27.6% | 7.1% | |
| LTM Jun 2026 | $114.48M | +334.7% | — | 20.4% | |
WGSGeneDx Holdings Corp. | LTM Jun 2026 | $106.36M | -7664.5% | -66.3% | 23.4% |
| LTM Mar 2026 | $74.56M | +78.1% | — | 23.3% | |
| LTM Jun 2026 | $51.88M | -50.1% | -9.2% | 6.8% | |
BLLNBillionToOne, Inc. | LTM Jun 2026 | $37.71M | — | — | 9.5% |
| Peer median (excluding BLLN) | $149.35M | +5.0% | -20.8% | 23.3% | |
Competitors are the stored peer set for BLLN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|
| Net Income | (82.68M) | (41.57M) | 2.92M |
| Depreciation & Amortization | 6.46M | 11.69M | 11.91M |
| Deferred Income Tax | 0 | 0 | 0 |
| Stock-Based Compensation | 4.85M | 8.36M | 15.92M |
| Change in Working Capital | 3.79M | (16.77M) | (22.05M) |
| Accounts Receivables | (2.59M) | (15.62M) | (16.91M) |
| Inventory | (1.41M) | (1.54M) | (8.81M) |
| Accounts Payables | 151K | 877K | 1.78M |
| Other Working Capital | 7.64M | (489K) | 1.89M |
| Other Non-Cash Items | 13.9M | (3.09M) | 15.91M |
| Operating Cash Flow | (53.67M) | (41.38M) | 24.6M |
| Capital Expenditures | (6.17M) | (5.4M) | (8.88M) |
| Acquisitions (Net) | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 |
| Sales of Investments | 90M | 0 | 0 |
| Other Investing Activities | (988K) | (31K) | 0 |
| Investing Cash Flow | 82.84M | (5.43M) | (8.92M) |
| Debt Repayment | 12.96M | 10.48M | (1.73M) |
| Common Stock Issued | 444K | 131.08M | 290.55M |
| Common Stock Repurchased | 0 | (546K) | 0 |
| Dividends Paid | 0 | 0 | 0 |
| Other Financing Activities | 0 | 0 | 0 |
| Financing Cash Flow | 13.41M | 141.02M | 288.83M |
| Effect of Forex Changes | 54.7M | 0 | 0 |
| Net Change in Cash | 97.27M | 94.21M | 304.5M |
| Free Cash Flow | (59.85M) | (46.78M) | 15.71M |
BillionToOne, Inc.
NASDAQ:BLLN
Intrinsic Alpha fair value
Locked
Current Price
$91.54
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.